Patented Serotonin Stimulant and Targeted Eating Weight Loss Results Published from ‘Real World’ Study | PR Newswire [Video]

Recent Progress in Nutrition has published a user study revealing a patented serotonin stimulant for weight loss, offering a promising, non-injectable alternative to GLP-1 agonists using safe, natural ingredients. This innovative approach provides new strategies to combat obesity without the chronic drug-related side effects of existing treatments.

, /PRNewswire-PRWeb/ — Greensboro, NC: A user study published in Recent Progress in Nutrition has examined a patented serotonin stimulant for weight loss. This oral, non-injectable approach promises an additional strategy to combat the global obesity epidemic. In contrast to GLP-1 (Glucagon-like peptide receptor agonists), compelling early results were achieved using a proprietary blend of safe, natural ingredients when combined with circadian nutrition.

Initially trademarked as Lactova™, the patented compound (Nos. 11,771,125 and 11,813,363) could offer an alternative to GLP-1 agonists, without chronic, costly, drug-induced appetite suppression. This approach could thus offer not only an alternative, but also an effective transition or “exit ramp” after GLP-1 weight loss therapy.

For further details, the …